Check 35,000+ stocks against 26 valuation models and 37 quality factors

Mitra Keluarga Karyasehat Tbk PT (MIKA) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Mitra Keluarga Karyasehat Tbk PT IDR 1,914, price IDR 1,740, upside +10.0%, quality 71 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

Fair value above price? Yes
Good quality? Yes
Add to watchlist

Healthcare · ID · ISIN ID1000135700

MK Thin data Sep 24, 2026

Mitra Keluarga Karyasehat Tbk PT

MIKA · JK

NeutralQuality growthThe stock looks roughly fairly valued with average quality.

·Fair value 1,914 IDR · Fairly valued (+10%)

✓Quality 71/100

!Expensive Growth (revenue 5y +9.4 %/yr)

✓Highly profitable · 25.3% net margin (TTM)

✓Low debt · generates free cash flow

✓Ranks above peers (11/15)

✓Wide moat 80/100

!Evidence only low, so the estimate is less certain

26 models, one by oneBear 1,202 IDR to bull 2,550 IDR Growth analysisrevenue history, year by year Quality 71/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Watch Mitra Keluarga Karyasehat Tbk PT for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 1,396 IDR – 3,128 IDR · fair‑value band 1,202 IDR – 2,550 IDR · the 1,740 IDR price screens below the 1,914 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Mitra Keluarga Karyasehat Tbk PT in your weekly email

Every Wednesday you see whether Mitra Keluarga Karyasehat Tbk PT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services. Its hospital network comprises Mitra Keluarga Hospitals and Kasih Group Hospitals located in Greater Jakarta, West Java, East Java, and Central Java. The company was founded in 1989 and is headquartered in Jakarta, Indonesia. PT Mitra Keluarga Karyasehat Tbk is a subsidiary of PT Griyainsani Cakrasadaya.

Stock analysis

Mitra Keluarga Karyasehat Tbk PT (MIKA) currently trades at 1,740 IDR, while our model-based Fair Value estimate is 1,914 IDR, implying the stock looks roughly 9.1% undervalued today.

Valuation

Bull case: the Growth Earnings group reads highest at a median of 1,736 IDR per share, and 8 of the 26 models we run sit above the 1,740 IDR price.

Bear case: the Asset-Based group reads lowest at 349.52 IDR, and 18 of the 26 models stay below the price. Evidence for this calculation is low.

Scenario range: 1,202 IDR (bear) to 2,550 IDR (bull), the price of 1,740 IDR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 71/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Mitra Keluarga Karyasehat Tbk PT reported revenue of 5.4T IDR in FY2025 versus 4.4T IDR in FY2021, a compound +5.4%/yr. Reported net income was 1.4T IDR in FY2025, compounding +2.7%/yr from FY2021.

Key figures

Market cap 24.2T IDR (≈ $2.4B) · P/E ratio 17.5 · P/S ratio 4.46 · EPS (TTM) 99.23 IDR · Dividend yield 2.5% · Net margin 25.4% · Return on equity 18.0% · Return on assets (EBIT) 19.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at 10%, MIKA screens richer than that median.

Fair Value models

Bear 1,202 IDR Fair Value 1,914 IDR Bull 2,550 IDR

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (72.59 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Highest evidence

FCF DCF 998.44 IDR 1,548 IDR 2,425 IDR 79

Growth DCF 997.56 IDR 1,513 IDR 2,311 IDR 78

Owner Earnings 811.12 IDR 1,235 IDR 1,910 IDR 76

All 26 models by family

DCF Models

FCF DCF 998.44 IDR 1,548 IDR 2,425 IDR 79

Owner Earnings 811.12 IDR 1,235 IDR 1,910 IDR 76

5Y Revenue Exit 980.03 IDR 1,537 IDR 2,276 IDR 72

5Y EBITDA Exit 1,363 IDR 2,298 IDR 3,448 IDR 74

5Y P/E Exit 1,427 IDR 2,427 IDR 3,541 IDR 70

10Y Revenue Exit 952.90 IDR 1,469 IDR 2,222 IDR 66

10Y EBITDA Exit 1,223 IDR 2,004 IDR 3,149 IDR 67

10Y P/E Exit 1,264 IDR 2,094 IDR 3,223 IDR 63

Earnings-Based

Graham-Dodd 667.36 IDR 2,720 IDR 3,702 IDR 64

Lynch FV 681.49 IDR 973.55 IDR 1,266 IDR 61

PEG = 1.0 681.49 IDR 973.55 IDR 1,266 IDR 57

EPV 1,017 IDR 1,149 IDR 1,263 IDR 74

Dividend Discount

Gordon GGM 377.67 IDR 752.54 IDR 1,140 IDR 67

DDM Multi-Stage 377.67 IDR 650.37 IDR 794.36 IDR 67

Multiples

P/E Multiple 1,619 IDR 2,159 IDR 2,699 IDR 63

P/S Multiple 1,013 IDR 1,351 IDR 1,689 IDR 58

P/B Multiple 1,251 IDR 1,668 IDR 2,085 IDR 55

EV/EBIT 1,699 IDR 2,205 IDR 2,710 IDR 66

EV/EBITDA 1,693 IDR 2,197 IDR 2,701 IDR 67

EV/Revenue 992.75 IDR 1,340 IDR 1,688 IDR 54

Asset-Based

NCAV (Graham) 260.83 IDR 349.52 IDR 521.67 IDR 54

Growth DCF

Growth DCF 997.56 IDR 1,513 IDR 2,311 IDR 78

Rev-Margin DCF 980.03 IDR 1,528 IDR 2,207 IDR 72

Economic Profit

Residual Income 613.72 IDR 789.56 IDR 2,381 IDR 65

ROIC Compounder 1,105 IDR 1,368 IDR 1,683 IDR 72

Growth Earnings

Growth-Adj P/E 1,215 IDR 1,736 IDR 2,257 IDR 67

Open the full fair value analysis →

Notify me when MIKA reaches fair value

Put MIKA on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 71/100

Of which business quality 70 · Market factors (momentum, volatility) 41

Profitability 70

Margins and returns on capital today

Quality Growth 50

Are margins and returns improving?

Cashflow 65

Earnings quality: real cash, not paper profit

Fin. Strength 98

Balance sheet, leverage, solvency risk

Investment 36

Disciplined investing over empire-building

Low Volatility 80

Calm price path (market factor)

Momentum 29

Price trend over the last 3–12 months (market factor)

52W Momentum 16

Distance to the 52-week high (market factor)

Net Issuance 84

Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100

The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Revenue growth 1 year

+10.1%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+9.9%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+9.4%

Start year 2020 (pandemic). Over 10 years: +9.6% a year

Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+10.4%

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

’25

What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.

+11.2%

Earnings growth per share plus dividend.

Earnings per share, growth per year+8.7%

Dividend (yield on the price)2.5%

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.11% vs 10%, steady

Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.33% → 31%

Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price

The price assumes more growth than the company has delivered so far and more than analysts expect.

What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).

+17.1%

Yearly growth needed for the next five years to justify today's price.

What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.

+9.6%

Yearly sales growth analysts expect, extended to five years.

After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about +14.1% a year for the price and +6.8% for the forecasts.

Forecast 2026 (sales)+10.5%

Forecast 2027 (sales)+11.1%

Projected 2028 (sales)+10.0%

Projected 2029 (sales)+8.8%

Projected 2030 (sales)+7.7%

Watch MIKA, get fair value alerts →

Compare Mitra Keluarga Karyasehat Tbk PT with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks

Beats the industry median on 11/15 measures

Overall it ranks above its industry peers.

Valuation

Quality Score 71 · Top 25%

Fair Value upside +10% · Above median

Profitability

Return on equity (TTM) 18% · Top 25%

Return on assets 12% · Top 25%

Net margin (TTM) 25% · Top 25%

Operating margin (TTM) 30% · Top 25%

Growth and dividend

Revenue growth 7% · Above median

Dividend yield (TTM) 2.5% · Above median

Balance sheet

Debt / equity 0.00× · Lowest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (TTM) 17.5× · Cheaper than median

P/B 3.34× · Priciest 25%

P/S (TTM) 4.44× · Priciest 25%

P/FCF 0.0× · Cheapest 25%

EV/EBITDA 10.5× · Pricier than median

PEG 1.41× · Pricier than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)47 · sector 33

FUTURE (revenue growth)33 · sector 29

PAST (return on equity)72 · sector 31

HEALTH (low debt)100 · sector 89

DIVIDEND (yield)50 · sector 42

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value
HCA Healthcare, Inc HCA	$438.12	$592.64	+35%
Fresenius SE FRE	€45.57	€34.54	−24%
Dr. Sulaiman Al Habib Medical Services Group 4013	227.50 SAR	109.45 SAR	−52%
IHH Healthcare Berhad, an investment holding company, 5225	8.00 MYR	4.87 MYR	−39%
Tenet Healthcare Corporation THC	$262.06	$399.58	+52%
DaVita Inc DVA	$183.72	$255.97	+39%
Apollo Hospitals Enterprise Limited APOLLOHOSP	₹9,069	₹2,908	−68%
Fresenius Medical Care AG FME	€39.30	€71.28	+81%
Aier Eye Hospital Group 300015	¥8.07	¥10.86	+35%
Encompass Health Corporation EHC	$122.76	$96.51	−21%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Run the numbers yourself: free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Mitra Keluarga Karyasehat Tbk PT · Fair Value
1,914 IDR +9%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/MIKA" target="_blank" rel="nofollow noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">Mitra Keluarga Karyasehat Tbk PT · Fair Value</span><br><b style="font-size:20px">1,914 IDR</b> <span style="color:var(--fvc-g-mitte);font-weight:700;font-size:14px">+9%</span></span><span style="font-size:11px;color:var(--fvc-g-mitte);font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "Mitra Keluarga Karyasehat Tbk PT Fair Value". https://www.fairvalue-calculator.com/stock/MIKA

Frequently asked questions

Is Mitra Keluarga Karyasehat Tbk PT (MIKA) overvalued or undervalued?

As of Sep 24, 2026, our model estimates a fair value of 1,914 IDR versus a price of 1,740 IDR, about +10% upside (undervalued).

What is the fair value of MIKA?

Our model-based fair value for Mitra Keluarga Karyasehat Tbk PT is 1,914 IDR (as of Sep 24, 2026), built from audited fundamentals. The current price: 1,740 IDR.

What is the quality score of MIKA?

Mitra Keluarga Karyasehat Tbk PT has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Our model-based price target is the fair value of 1,914 IDR (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 1,202 IDR, optimistic scenario 2,550 IDR. It is a calculation from audited fundamentals, not an analyst target.

What is the Mitra Keluarga Karyasehat Tbk PT stock forecast for 2026?

Our models put fair value at 1,914 IDR, about +10% upside versus a price of 1,740 IDR (undervalued). Cautious scenario 1,202 IDR, optimistic scenario 2,550 IDR. The calculation is refreshed regularly with new filings.

What is the revenue of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Mitra Keluarga Karyasehat Tbk PT reported trailing-twelve-month revenue of about 5.5T IDR (latest available figure, as of Sep 24, 2026).

Does Mitra Keluarga Karyasehat Tbk PT pay a dividend?

Mitra Keluarga Karyasehat Tbk PT currently shows a dividend yield of about 2.52% relative to its recent price (as of Sep 24, 2026).

What growth is priced into Mitra Keluarga Karyasehat Tbk PT (MIKA)?

For today's price to be fair in a discounted-cash-flow model, Mitra Keluarga Karyasehat Tbk PT would have to grow free cash flow by +17.1 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.4 % per year. As of Sep 24, 2026.

What discount rate (WACC) does the fair value of MIKA use?

Our models discount Mitra Keluarga Karyasehat Tbk PT at 12.0 %: a base by market capitalisation (mid), country premium for Indonesia. The same rate applies in all 26 models.

What is a reverse DCF?

A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Mitra Keluarga Karyasehat Tbk PT that is +17.1 % per year a year over ten years, using the same discount rate (12.0 %) and the same formula as our fair value.

How much growth has Mitra Keluarga Karyasehat Tbk PT (MIKA) delivered so far?

Over the past 5 years revenue at Mitra Keluarga Karyasehat Tbk PT grew +9.4 % a year. The price currently implies +17.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.

How fast is the sector of Mitra Keluarga Karyasehat Tbk PT (MIKA) growing?

The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Mitra Keluarga Karyasehat Tbk PT (+17.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.

What is the free cash flow yield of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The free-cash-flow yield on the price is 3.96 %: that much free cash flow Mitra Keluarga Karyasehat Tbk PT produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.

What is the intrinsic value of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Mitra Keluarga Karyasehat Tbk PT it is 1,914 IDR per share (as of Sep 24, 2026), against a price of 1,740 IDR. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).

Is Mitra Keluarga Karyasehat Tbk PT stock overvalued or undervalued in 2026?

As of Sep 24, 2026, MIKA trades below its calculated fair value: price 1,740 IDR, fair value 1,914 IDR, a gap of about +10% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of MIKA?

No. The price is what the market pays today (1,740 IDR); the fair value is what the company's own numbers justify (1,914 IDR). For Mitra Keluarga Karyasehat Tbk PT the two are 174.00 IDR per share apart. That gap is exactly why we show both numbers side by side.

How much is Mitra Keluarga Karyasehat Tbk PT worth?

The market values Mitra Keluarga Karyasehat Tbk PT at about 24.2T IDR (market capitalisation, as of Sep 24, 2026). Per share that is 1,740 IDR; our models calculate a fair value of 1,914 IDR per share.

What do the bullish and bearish scenarios say about MIKA?

Our models span a range for Mitra Keluarga Karyasehat Tbk PT: cautious scenario 1,202 IDR, base 1,914 IDR, optimistic 2,550 IDR per share (as of Sep 24, 2026, price 1,740 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of MIKA?

Mitra Keluarga Karyasehat Tbk PT trades at a price-to-earnings ratio of 17.5 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1,914 IDR is built from several models across several years. Other multiples: PEG 1.4, P/B 3.3, P/S 4.4, EV/EBITDA 10.5.

What is the PEG ratio of MIKA?

The PEG ratio of Mitra Keluarga Karyasehat Tbk PT is 1.41 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.

How solid is the balance sheet of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Balance-sheet figures for Mitra Keluarga Karyasehat Tbk PT (as of Sep 24, 2026): return on equity 18.0%, debt of 0.00 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.

How far is MIKA from its 52-week high?

Mitra Keluarga Karyasehat Tbk PT trades at 1,740 IDR, about 33% below its 52-week high of 2,597 IDR and 25% above the low of 1,396 IDR (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 1,914 IDR is for.

Which stocks are comparable to Mitra Keluarga Karyasehat Tbk PT?

From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Mitra Keluarga Karyasehat Tbk PT stock attractive at the current price?

The data as of Sep 24, 2026: price 1,740 IDR, calculated fair value 1,914 IDR (+10%), Quality Score 71/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of MIKA calculated?

We run Mitra Keluarga Karyasehat Tbk PT through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1,914 IDR, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 14.1 % above its aggregate fair value. Mitra Keluarga Karyasehat Tbk PT currently trades 10 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The closing price on Sep 23, 2026 was 1,740 IDR. Our model-based fair value is 1,914 IDR, about +10% upside (undervalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Mitra Keluarga Karyasehat Tbk PT right now?

A fairly wide model range (1,202 IDR to 2,550 IDR) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Where does the earnings growth of Mitra Keluarga Karyasehat Tbk PT (MIKA) come from?

Earnings per share at Mitra Keluarga Karyasehat Tbk PT grew +7.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +9.6 %, EBIT margin +0.2 %, tax rate −0.3 %, residual (interest, one-offs) −1.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Mitra Keluarga Karyasehat Tbk PT

How large is the market capitalisation of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The market capitalisation of Mitra Keluarga Karyasehat Tbk PT is 24.2T IDR (≈ $2.4B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The price-to-sales ratio of Mitra Keluarga Karyasehat Tbk PT is 4.46 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Earnings per share at Mitra Keluarga Karyasehat Tbk PT are 99.23 IDR (price ÷ EPS = P/E 17.5). Earnings per share over the last twelve months: total profit spread across every single share.

What is the dividend yield of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The dividend yield of Mitra Keluarga Karyasehat Tbk PT is 2.5% (payout 44.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.

What is the net margin of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The net margin of Mitra Keluarga Karyasehat Tbk PT is 25.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The return on equity (ROE) of Mitra Keluarga Karyasehat Tbk PT is 18.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

On an EBIT basis the return on assets of Mitra Keluarga Karyasehat Tbk PT is 19.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Mitra Keluarga Karyasehat Tbk PT (MIKA)?

The operating margin of Mitra Keluarga Karyasehat Tbk PT is 30.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Revenue at Mitra Keluarga Karyasehat Tbk PT is growing +6.6% versus a year earlier (3y avg +9.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Mitra Keluarga Karyasehat Tbk PT (MIKA)?

Earnings per share at Mitra Keluarga Karyasehat Tbk PT are growing +4.8% versus a year earlier. How much earnings per share grew versus a year earlier.

How much net cash does Mitra Keluarga Karyasehat Tbk PT (MIKA) hold?

Mitra Keluarga Karyasehat Tbk PT holds more cash than debt, 2.5T IDR net (fiscal year 2025). The company holds more cash than debt, a safety cushion.

Free · no account needed

Watch Mitra Keluarga Karyasehat Tbk PT in the live analysis

One click puts Mitra Keluarga Karyasehat Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.